FDA Hammers 2 More Drugmakers Over Bad Ads
The U.S. Food and Drug Administration on Thursday released two warning letters that sharply rebuked drugmakers for promotional pieces that downplayed product risks, joining two other letters this week and marking...To view the full article, register now.
Already a subscriber? Click here to view full article